Recruiting NA Balance Assessment

New treatment option for Balance Assessment

Official title Development of a Static Balance Assessment Tool for High-Functioning Older Adults (KSVGH25-CT3-09)

ClinicalTrials.gov ID: NCT07300592

What this study is testing

What it's testing
This single-center interventional study aims to develop and validate a static balance assessment tool tailored for high-functioning older adults. Participants aged 65 years or older, who achieve a perfect score on the Short Physical Performance Battery and can maintain an open-eyes single-leg stance for at least 10 seconds, will be recruited.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 60 to 80. Healthy volunteers may be eligible.

You may be able to join if

  • Age 60 to 85 years
  • Able to walk independently without assistive devices
  • No self-reported balance disorders or history of recurrent falls in the past 6 months
  • Cognitively intact (Mini-Mental State Examination score ≥ 24)
  • Willing and able to provide informed consent

You likely can't join if

  • Diagnosed neurological disorders affecting balance (e.g., Parkinson's disease, stroke with residual deficits)
  • Diagnosed neurological disorders affecting balance (e.g., Parkinson's disease, stroke with residual deficits)
  • Severe visual or vestibular impairment uncorrected by aids
  • Lower limb musculoskeletal disorders that limit mobility
  • Current participation in other treatment clinical trials
  • Unstable cardiovascular conditions (e.g., uncontrolled hypertension, recent myocardial infarction)
See the full eligibility criteria
Who can join
  • Age 60 to 85 years
  • Able to walk independently without assistive devices
  • No self-reported balance disorders or history of recurrent falls in the past 6 months
  • Cognitively intact (Mini-Mental State Examination score ≥ 24)
  • Willing and able to provide informed consent
What rules you out
  • Diagnosed neurological disorders affecting balance (e.g., Parkinson's disease, stroke with residual deficits)
  • Diagnosed neurological disorders affecting balance (e.g., Parkinson's disease, stroke with residual deficits)
  • Severe visual or vestibular impairment uncorrected by aids
  • Lower limb musculoskeletal disorders that limit mobility
  • Current participation in other treatment clinical trials
  • Unstable cardiovascular conditions (e.g., uncontrolled hypertension, recent myocardial infarction)
  • Severe visual or vestibular impairment uncorrected by aids
  • Lower limb musculoskeletal disorders that limit mobility
  • Current participation in other treatment clinical trials
  • Unstable cardiovascular conditions (e.g., uncontrolled hypertension, recent myocardial infarction)

The study team makes the final eligibility decision.

Where it's taking place

  • Kaohsiung City, Kaohsiung City, Taiwan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 60 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Kaohsiung City, Kaohsiung City, Taiwan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.